AI eye test for multiple eye diseases
Part of Eyes & vision clinical trials.
This trial uses artificial intelligence to analyze eye images and help diagnose and prioritize eye conditions. It could help find the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to read and understand Chinese or English.
- If you are a healthy participant, you must have no eye concerns.
- If you have eye symptoms, you must have a specific eye issue to report.
- Your medical records must be complete enough for a final diagnosis.
- You must be stable enough to safely join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new artificial intelligence system that helps eye doctors make decisions. You may qualify if you are having a routine eye exam and can get clear images of both eyes.
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
This trial tests how artificial intelligence can help doctors make better decisions about eye diseases. It may be a good fit if you have an eye condition and can share your medical records and images.
This trial tests an artificial intelligence (AI) tool that uses eye images to help doctors diagnose breathing or lung-related conditions. If you have a lung/breathing problem and can do both eye and lung checkups, it may support faster or more accurate diagnosis.
This trial tests a new AI-powered, do-it-yourself screening system for diabetic retinopathy. It may help find early signs of eye disease in people who haven't had an eye exam in the past year.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
Hear when a new Anterior Segment Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.